These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


100 related items for PubMed ID: 11566048

  • 21. The role of myelin in Theiler's virus persistence in the central nervous system.
    Roussarie JP, Ruffié C, Brahic M.
    PLoS Pathog; 2007 Feb; 3(2):e23. PubMed ID: 17305428
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The course of disease and persistence of virus in the central nervous system varies between individual CBA mice infected with the BeAn strain of Theiler's murine encephalomyelitis virus.
    Simas JP, Fazakerley JK.
    J Gen Virol; 1996 Nov; 77 ( Pt 11)():2701-11. PubMed ID: 8922463
    [Abstract] [Full Text] [Related]

  • 25. Quantitative, not qualitative, differences in CD8(+) T cell responses to Theiler's murine encephalomyelitis virus between resistant C57BL/6 and susceptible SJL/J mice.
    Lyman MA, Myoung J, Mohindru M, Kim BS.
    Eur J Immunol; 2004 Oct; 34(10):2730-9. PubMed ID: 15368289
    [Abstract] [Full Text] [Related]

  • 26. Susceptibility of peritoneal macrophages to infection by Theiler's virus.
    Jelachich ML, Reddi HV, Trottier MD, Schlitt BP, Lipton HL.
    Virus Res; 2004 Sep 01; 104(2):123-7. PubMed ID: 15246649
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Simplified quantitative analysis of spinal cord cells from Theiler's virus-infected mice without the requirement for myelin debris removal.
    Lipton HL, Kallio P, Jelachich ML.
    J Immunol Methods; 2005 Apr 01; 299(1-2):107-15. PubMed ID: 15914195
    [Abstract] [Full Text] [Related]

  • 29. Establishment of a model to examine the early events involved in the development of virus-induced demyelinating lesions.
    Drescher KM, Tracy S.
    Ann N Y Acad Sci; 2007 Apr 01; 1103():152-6. PubMed ID: 17376832
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide.
    Mendez-Fernandez YV, Johnson AJ, Rodriguez M, Pease LR.
    Eur J Immunol; 2003 Sep 01; 33(9):2501-10. PubMed ID: 12938226
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Replication of Theiler's virus requires NF-kappa B-activation: higher viral replication and spreading in astrocytes from susceptible mice.
    Kang MH, So EY, Park H, Kim BS.
    Glia; 2008 Jul 01; 56(9):942-53. PubMed ID: 18383344
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. DA virus mutant H101 has altered CNS pathogenesis and causes immunosuppression.
    Cusick MF, Libbey JE, Doty DJ, Fujinami RS.
    J Neuroimmunol; 2014 Dec 15; 277(1-2):118-26. PubMed ID: 25468274
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Post-stress state and communicative alterations of immunity and blood].
    Surinov BP, Karpova NA, Isaeva VG, Kulish IuS.
    Patol Fiziol Eksp Ter; 2000 Dec 15; (4):9-11. PubMed ID: 11247137
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.